Non-muscle Invasive Bladder Cancer Clinical Trials in San Antonio, Texas

4 studies are recruiting for non-muscle invasive bladder cancer in San Antonio, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

    The purpose of this study is to learn how a new medicine called PF-08052667 works when used by itself or together with another medicine called Bacillus Calmette Guerin (BCG), and/or a medicine called sasanlimab. This study is for adults who have a type of bladder cancer that hasn't spread into the …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Baptist M&S Imaging (Medical Center), San Antonio, Texas
    Locations
    68 in total
    Run by
    Pfizer
  2. Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

    This is a multi-center study and the aim is to develop and validate an Artificial Intelligence (AI) -based histologic analysis tool to predict responsiveness to intravesical Bacillus Calmette-Guérin (BCG) and intravesical chemotherapy in intermediate and high-risk non-muscle invasive bladder cancer…

    Stage
    Not phased
    Ages
    18 to 99
    Site
    University of Texas Health Science Center at San Antonio, San Antonio, Texas
    Locations
    2 in total
    Run by
    University of Texas Southwestern Medical Center
  3. Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

    TARA-002-101-Ph2 is an open-label study to investigate the safety and efficacy of intravesical instillation of TARA-002 in adults 18 years of age or older with high-grade CIS NMIBC (± Ta/T1). The purpose of this Phase 2 study (TARA-002-101-Ph2) is to further assess the safety and efficacy of TARA-0…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    UT Health San Antonio, San Antonio, Texas
    Locations
    78 in total
    Run by
    Protara Therapeutics
  4. A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

    This is a first-in-human (FIH), Phase 1/2a, multi center, open-label, single treatment, dose escalation and expansion study designed to determine the safety and tolerability of STM-416 in patients with bladder cancer.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Texas Health Science Center at San Antonio, San Antonio, Texas
    Locations
    20 in total
    Run by
    SURGE Therapeutics

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.